TEVA-NABILONE
TEVA-NABILONE
Approved
DIN Number
02384884
Drug Class
Human
Market Date
May 23, 2012
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02384884
AIG Number0115009002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA II)
A
ATC Code
A04AD11 NABILONE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:22.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
NABILONEActive
Strength: 0.5 MG
Monograph: NABILONE